Marijuana Growing, Medical Marijuana, Weed, weed news

Canopy Growth Corp (TSE:WEED) Volume Stalls Out, What Comes Next for Cannabis Trade?

weed growing

Canopy Growth Corp (OTCMKTS:TWMJF) (FRA:11L1) enjoyed a strong run, as did the rest of the cannabis trade complex. Much of the technical damage experienced over the past 10-weeks has been mitigated, to a significant degree. But with prices stalling out and volume grinding lower, bulls are seemingly running out of steam. We take look at what comes next for Canopy and the rest of the sector.

Currently, Canopy Growth is trading higher by $0.37 to $30.23/share (↑1.24%). Although they announced a modest supply agreement with Yukon Liquor Corporation to provide up to 900 kg of cannabis products for the upcoming adult retail market, the news hasn’t seemingly had much impact. Neither relative price vis-à-vis its peers, nor volume has really excited today.

The same holds true for the cannabis market in general. The Horizons Marijuana Life Sciences Index ETF(TSE:HMMJ) has currently flatlined, now down ↓0.12% after peeking modestly higher around 11am. Other sector co-leader, Aurora Cannabis Inc, has joined the buyer’s strike, falling below the $8.70/share pivot range we initially wrote about last week. Trading volumes look to finish anywhere between ↓25-50% below average for most of the sector; Canopy Growth may not even make it that far.

Company Last Change Change % Volume
Hiku Brands Company Ltd. 1.78 0.12 7.23% 288.93k
Canopy Growth Corporation 30.6 0.74 2.48% 3.14m
Aurora Cannabis Inc. 8.63 0.19 2.25% 7.38m
Abcann Global Corporation 1.61 0.03 1.90% 707.69k
The Hydropothecary Corporation 4.14 0.07 1.72% 869.17k
THC Biomed Intl Ltd 1.35 0.02 1.50% 175.99k
Emblem Corp 1.55 0.02 1.31% 483.13k
MYM Nutraceuticals Inc 1.71 0.01 0.59% 333.90k
CannTrust Holdings Inc. 6.45 0.01 0.16% 263.52k
CanniMed Therapeutics Inc. 33.54 0.01 0.03% 84.69k
Maricann Group Inc. 1.75 0 0.00% 1.22m
Namaste Technologies Inc 1.61 0 0.00% 1.11m
WeedMD Inc. 1.58 -0.01 -0.63% 123.77k
InMed Pharmaceuticals Inc. 1.27 -0.01 -0.78% 162.58k
Emerald Health Therapeutics Inc. 4.85 -0.05 -1.02% 648.33k
MedReleaf Corp. 18.99 -0.2 -1.04% 164.26k
The Supreme Cannabis Company Inc. 1.68 -0.02 -1.18% 575.82k
Cronos Group Inc. 7.33 -0.11 -1.48% 1.55m
OrganiGram Holdings Inc 3.89 -0.06 -1.52% 405.11k
Aphria Inc. 11.14 -0.2 -1.76% 4.33m
Newstrike Resources Ltd. 1.01 -0.02 -1.94% 1.07m
Invictus MD Strategies Corp 1.89 -0.04 -2.07% 346.87k
Cannabis Wheaton Income Corp. 1.54 -0.05 -3.14% 1.65m
Cannabix Technologies Inc 1.97 -0.08 -3.90% 777.10k
Isodiol International Inc. 0.96 -0.09 -8.57% 5.11m

 

With Canopy Growth approaching $30.00/share and the 50-Day MA just under, let’s look at the updated technical take:

weed chart

Credit: midasletter.com

From my perspective, buying programs attempted to rally WEED between 10:30-10:50am this morning after three successful defenses of the 50-Day MA ($29.72). Although buyers were able to pierce the underside of the April 16 upper channel, zero follow-through occurred. Volume has again collapsed, suggesting that buyers have given up on the attempt. This leaves Canopy Growth oscillating aimlessly within the recent channel, trending back towards the 50-Day MA.

From here, a couple of likely scenarios exist:

1) Prices begin to drift down towards the ’50’, where yet another defense by the bulls will need to be waged.

2) Prices consolidate above the ’50’, and bulls regroup with added impetus to test channel highs.

All things considered, I believe scenario #1 is the most likely one. The buying algos have already showed their hand, and failed to generate much interest at & above near term resistance points. Furthermore, overall market volume is not supportive of a higher, generalized move forward. Canopy Growth has released several smaller press releases which have failed to move the needle much. Today’s supply agreement—albeit modest in the greater scheme of things—is no exception.

However, it’s worth noting that bulls remain in charge until otherwise noted, so both scenarios are very much in play.

The key short term technical levels are as follows:

↑$30.50-30.65: ST target $32.00 area with possible buy-side extension to $34.75

↓$29.50: ST target to $28.60 with possible sell-side extension to $26.50 area

Depending on what occurs next, Canopy could easily see extensive positional jockeying around the ’50’ as experienced in early March. Surely, that wasn’t a fun time for Canopy swing traders looking to make a few points. Considering the narrowing triangular configuration currently ongoing, the potential for much near term noise exists. This may manifest itself in positional jockeying around its 50/100-Day MA before picking a broader direction.

Looking at the bigger picture, I believe the potential exists for the long-anticipated Canadian legalization trade to occur if/when Canopy Growth breaks out of its ascending triangle. There’s a lot of pent up energy and demand in that formation—but we’re not there yet. It’s certainly something we’re keeping an eye on as we grind towards the late innings.

Investors looking to optimize entry points should position accordingly.

Credit: midasletter.com

Related Posts